Take a look at what has been happening in the Cataract & Refractive fields in 2007.
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.
Topcon Healthcare, Inc. appoints Krysten Williams Head of Digital Solutions & Clinical Development – EMEA
Williams joins Topcon Healthcare from Heidelberg Engineering, where she held multiple senior leadership roles.
PHOTON Results and Their Relation to DME Patients in Your Practice
John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.
Teprotumumab (Tepezza, Amgen) receives marketing authorisation from MHRA
Teprotumumab is the first therapy specifically licensed for the treatment of moderate-to-severe thyroid eye disease in the UK
PULSAR Results and Their Relation to nAMD Patients in Your Practice
John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.
Isarna Therapeutics shares positive results from Phase 2 BETTER trial
OPGX-LCA5 gene therapy phase 1/2 data support potential to restore meaningful vision
Opus Genetics reveals promising 1-year results from OPGx-LCA5 gene therapy, showing sustained vision improvements in adults with LCA5 retinal degeneration.